Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

Go back to Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution
(NASDAQ: KNSA) Delayed: 78.63 +0.55 (0.70%)
Previous Close $78.08    52 Week High
Open $78.00    52 Week Low
Day High $78.96    P/E N/A 
Day Low $76.65    EPS
Volume 428,070